Ziyang Wang

9PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 31, 2025
SIRT5-mediated desuccinylation of PPA2 enhances HIF-1alpha-dependent adaptation to hypoxic stress and colorectal cancer metastasis.

Xiang Zhang, Yuqin Di, Youpeng Wang

|Nov 20, 2024
NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer.

Ziyang Wang, Yuqin Di, Xiangqiong Wen

|Sep 18, 2024
ACSL6-activated IL-18R1-NF-κB promotes IL-18-mediated tumor immune evasion and tumor progression.

Yuqin Di, Ziyang Wang, Jing Xiao

|Aug 09, 2024
MAPK Signaling-Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin-Induced Apoptosis and Ferroptosis.

Yuqin Di, Xiang Zhang, Xiangqiong Wen

|Mar 08, 2024
Metabolism-regulated ferroptosis in cancer progression and therapy.

Lvlan Ye, Xiangqiong Wen, Jiale Qin

|Jan 08, 2023
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance.

Ziyi Zhao, Yong Mei, Ziyang Wang

Pageof 2

Frequent Collaborators

4 joint publications

Yuqin Di

3 joint publications

Chunjie Sheng

3 joint publications

Shuai Chen

3 joint publications

Xiang Zhang